Interní Med. 2013; 15(10): 318-320

Combined dyslipidaemia secondary to severe hypothyreosis

MUDr.Ľubica Cibičková, Ph.D., doc.MUDr.David Karásek, Ph.D.
Fakultní nemocnice Olomouc, 3. interní klinika &ndash, nefrologická, revmatologická, endokrinologická

We describe a case of a young man, who presented with combined dyslipidaemia with predominant elevation of total and LDL cholesterol.

Severe thyroid hypofunction due to long undiagnosed Hashimoto thyroiditis was found to be the underlying cause. The lipid parameters

gradually improved in response to substitution. This case report underlines the importance of excluding hypothyroidism as the most

common aetiology of secondary dyslipidaemia.

Keywords: dyslipidaemia, hypothyreosis, Hashimoto thyroiditis

Published: October 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cibičková Ľ, Karásek D. Combined dyslipidaemia secondary to severe hypothyreosis. Interní Med. 2013;15(10):318-320.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Češka R. Sekundární hyperlipoproteinémie. In: Cholesterol a ateroskleróza, léčba dylipidémií. Triton 2012: 85-86.
    2. Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin N Am 2012; 96: 269-281. Go to original source... Go to PubMed...
    3. Series JJ, Biggart EM, O´Reilly DS et al. Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. Clin Chim Acta 1988; 172: 217-221. Go to original source... Go to PubMed...
    4. Bindels AJ, Westendorp RG, Frolich M et al. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case finding? Clin Endocrinol (Oxf) 1999; 50: 217-220. Go to original source... Go to PubMed...
    5. Límanová Z, Fiedler J, Češka R. Are thytroid fiction disturbances correctly diagnosed before hypolipidemic drugs administration? The Thyroid Gland 2000; 1: 19-27.
    6. Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidaemia. Arch Intern Med 1995; 155(14): 1490-1495. Go to original source...
    7. Sarzosa Terán V, Astudillo Calle MA. Relationship of thyroid-stimulating hormone levels to development of dyslipidemia and determination of an ideal cut-off point to start replacement therapy. Endocrinol Nutr. 2012; 59(10): 575-582. Go to original source... Go to PubMed...
    8. Duntas LH. Thyroid disease and lipids. Thyroid; 2002: 12(4): 287-293. Go to original source... Go to PubMed...
    9. Jiskra J, Límanová Z, Antošová M. Tyreopatie, dyslipidémie a kardiovaskulární rizika. Vnitř Lék 2007; 53(4): 382-385. Go to PubMed...
    10. Tanaci N, Ertugrul DT, Sahin M, Yucel M, Olcay I, Demirag NG, Gursoy A. Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism. Endocrine 2006; 29(3): 451-456. Go to original source... Go to PubMed...
    11. Tokinaga K, Oeda T, Suzuki Y, Matsushima Y. HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism Endocr J 2006; 53(3): 401-405. Go to original source... Go to PubMed...
    12. Doporučení pro laboratorní diagnostiku funkčních a autoimunních onemocnění štítné žlázy. Klin Biochem Met 2011; 1: 48-60.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.